Is Zytiga in Shortage in 2026?

If you've been searching for Zytiga and coming up empty-handed, you're probably wondering whether there's an official shortage. The short answer: as of early 2026, Zytiga (Abiraterone Acetate) is not listed as being in shortage by the FDA. Generic Abiraterone Acetate is also not on the FDA's drug shortage list.

So why does it feel like there's a shortage? Because for many patients, the practical experience of trying to find Zytiga feels exactly like a shortage — even when the supply technically exists. The real barriers are access-related: specialty pharmacy distribution, prior authorization delays, and the high cost of keeping this medication in stock.

Let's break down the full picture for 2026.

Why Is Zytiga Hard to Find If There's No Shortage?

Even without a formal shortage, several factors make Zytiga difficult to locate at your local pharmacy.

Specialty Distribution Channels

Zytiga is classified as a specialty drug, meaning it's distributed through a limited network of specialty pharmacies rather than through typical retail pharmacy supply chains. Your neighborhood CVS, Walgreens, or independent pharmacy almost certainly doesn't stock it. This isn't because the drug is unavailable — it's because the distribution system is designed to funnel it through specific channels.

Prior Authorization Bottlenecks

Most insurance plans require prior authorization for Zytiga. This administrative step confirms that the drug is medically necessary before the insurer will pay for it. While important for controlling costs, prior authorization can delay access by days or weeks — creating the experience of a shortage even when supply exists.

Limited Pharmacy Inventory

With a cash price of $12,000 to $14,000 per month for brand-name Zytiga, pharmacies face significant financial risk by stocking it. If a patient doesn't pick up their order, the pharmacy may be stuck with thousands of dollars in unsold inventory. As a result, many pharmacies only order Zytiga after receiving a specific prescription and insurance approval.

How Much Does Zytiga Cost in 2026?

Cost remains one of the biggest challenges for patients who need Zytiga. Here's a realistic breakdown:

• Brand-name Zytiga: Approximately $12,000 to $14,000 per month without insurance
• Generic Abiraterone Acetate: Approximately $500 to $3,000 per month without insurance, depending on the pharmacy and quantity
• Yonsa (alternative brand): Pricing varies but is generally in a similar range to brand-name Zytiga
• With insurance: Copays vary widely. Specialty tier drugs can have copays of $100 to $500+ per month even with good coverage

For information on reducing these costs, see our full guide on how to save money on Zytiga in 2026.

Are There New Options in 2026?

The landscape for prostate cancer treatment continues to evolve. In addition to Zytiga and its generic, patients and doctors now have several alternatives:

• Generic Abiraterone Acetate — same drug as Zytiga, often significantly less expensive and increasingly available
• Yonsa — a micronized formulation of Abiraterone Acetate that can be taken with or without food, unlike Zytiga
• Enzalutamide (Xtandi) — an androgen receptor inhibitor that doesn't require an empty stomach or prednisone
• Apalutamide (Erleada) and Darolutamide (Nubeqa) — newer androgen receptor inhibitors with different side effect profiles

For a deeper comparison of these options, read our article on alternatives to Zytiga.

How to Find Zytiga in Stock Right Now

If you need Zytiga and your current pharmacy doesn't have it, here are your best next steps:

1. Search on Medfinder — check real-time availability at pharmacies near you
2. Contact your oncologist's office — they can direct you to their preferred specialty pharmacy
3. Call your insurance company's specialty pharmacy line — they can tell you exactly which pharmacies are in-network and may have stock
4. Ask about generic Abiraterone Acetate — it's the same medication and may be easier to find
5. Start refills early — give yourself at least two weeks of lead time before running out

For more detailed tips, check out our guide on how to find Zytiga in stock near you.

Final Thoughts

There is no official shortage of Zytiga in 2026, but that doesn't mean it's easy to find. Specialty distribution, prior authorization requirements, and high costs create real access barriers that can feel just as frustrating as a true drug shortage.

The key is to plan ahead, use available tools like Medfinder, and stay in close contact with your oncology care team. If you're struggling with cost, patient assistance programs from the Johnson & Johnson Patient Assistance Foundation and savings programs like Janssen CarePath can make a meaningful difference.

You deserve timely access to the medication your doctor prescribed. Don't let logistics stand in the way of your treatment.